Organon & Co | OGN - Market Capitalization

Stock Price
8.00
Daily Change
-0.20 -2.44%
Monthly
7.53%
Yearly
-46.58%
Q1 Forecast
8.28

Organon & Co reported $2.1B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Celltrion KRW 40.04T 3.19T Sep/2025
Cspc Pharmaceutical CNY 107.03B 26.09B Sep/2025
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Divis Laboratories Ltd INR 1.51T 297.32B Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
Laboratorios Farma EUR 3.68B 430.05M Jan/2026
Malin Corporation EUR 150.45M 12.13M Jan/2026
Medical Developments International AUD 61.96M 16.34M Jun/2025
Merck USD 294.09B 84.45B Feb/2026
Neuren Pharmaceuticals AUD 1.75B 152.5M Jun/2025
Novartis USD 303.91B 57.84B Feb/2026
Organigram Holdings CAD 191.77M 187.03M Feb/2026
Organon & Co USD 2.18B 593.28M Feb/2026
Pharma Mar EUR 1.63B 241.7M Sep/2025
Qiagen NV USD 9.69B 719.54M Sep/2025
Sartorius EUR 8.73B 4.72B Feb/2026
Sino Biopharmaceutical CNY 90.06B 33.55B Jun/2025